Maryland – Specimen-news.com

NIH launches clinical trial of universal influenza vaccine candidate

By thespecimennews on June 2, 2021 • ( 0 )

A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. Healthy… Read More ›

NIH leadership details unprecedented initiative to ramp up testing technologies for COVID-19

By thespecimennews on July 23, 2020 • ( 0 )

In a paper in the New England Journal of Medicine(link is external), scientific leaders from the National Institutes of Health set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for underserved populations that have been disproportionally affected by the disease.

NIH begins study to quantify undetected cases of coronavirus infection

By thespecimennews on April 11, 2020 • ( 0 )

A new study has begun recruiting at the National Institutes of Health in Bethesda, Maryland, to determine how many adults in the United States without a confirmed history of infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), have antibodies to the virus.

NIH and Children’s National partner to advance pediatric clinical research

By thespecimennews on September 18, 2018 • ( 0 )

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and Children’s National Health System, a pediatric academic medical center in Washington, D.C., have launched a clinical research partnership devoted to treating and preventing allergic, immunologic and infectious diseases in children.